JP Morgan Chase
APTO

JP Morgan Chase’s Aptose Biosciences, Inc. APTO Stock Holding History

JP Morgan Chase’s Portfolio APTO Stock Details APTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-36
Closed -$8 – 7882
2025
Q1 		$8 Buy
+36
New +$175 ﹤0.01% 7207
2021
Q4 		– Hold
0
– – – 7120
2021
Q3 		– Hold
0
– – – 6948
2021
Q2 		– Hold
0
– – – 6287
2021
Q1 		– Hold
0
– – – 6003
2020
Q2 		– Sell
-5
Closed -$13K – 5805
2020
Q1 		$13K Sell
5
-79
-94% -$236K ﹤0.01% 5022
2019
Q4 		$213K Sell
84
-102
-55% -$133K ﹤0.01% 4642
2019
Q3 		$174K Buy
+186
New +$212K ﹤0.01% 4693
2018
Q1 		– Sell
-48
Closed -$49K – 5698
2017
Q4 		$49K Buy
+48
New +$37.1K ﹤0.01% 4908

Other funds holding APTO

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
GG
Gleason Group Prospect, Kentucky $1.15B AUM 21.11% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return
CSC
Caldwell Sutter Capital Sausalito, California $246M AUM 23.62% 1-Year Est. Return

JP Morgan Chase's APTO Position: Q2 2025 in Review

JP Morgan Chase sold out of Aptose Biosciences, Inc. (APTO) in Q2 2025, closing a stake of 36 shares — an estimated $8 sold.

JP Morgan Chase first reported a position in APTO in Q4 2017 and held it in 5 quarters. The position peaked at $213K in Q4 2019. 4 funds tracked by Wall St. Rank hold APTO as of Q2 2025.

  • JP Morgan Chase reported no remaining Aptose Biosciences, Inc. position as of Q2 2025 after selling out during the quarter.
  • JP Morgan Chase sold 36 Aptose Biosciences, Inc. shares in Q2 2025, an estimated $8.
  • JP Morgan Chase first reported a position in Aptose Biosciences, Inc. in Q4 2017 and held it in 5 quarters.
  • JP Morgan Chase's Aptose Biosciences, Inc. position peaked at $213K in Q4 2019.
  • 4 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q2 2025.

Based on JP Morgan Chase's 13F filing for Q2 2025, filed 12 Aug 2025.